Literature DB >> 6174110

Effect of interferon on plasma lipoproteins and on the activity of postheparin plasma lipases.

C Ehnholm, K Aho, J K Huttunen, E Kostiainen, K Mattila, J Pakkarainen, K Cantell.   

Abstract

The effect of interferon administration on the concentration of plasma lipoproteins and on the activity of postheparin plasma lipoprotein lipase and hepatic lipase was studied in six healthy men. Daily injection of human leukocyte interferon for 1 week lowered the plasma level of total cholesterol, very low density lipoprotein + low density lipoprotein cholesterol, high density lipoprotein cholesterol, and apolipoprotein A-1 in all subjects. Simultaneously, the activity of postheparin plasma hepatic lipase and lipoprotein lipase decreased by 20% to 50%. These observations may be of importance in the interpretation of lipoprotein changes seen in acute and chronic infections and should be borne in mind when prolonged treatment with interferon is considered.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6174110     DOI: 10.1161/01.atv.2.1.68

Source DB:  PubMed          Journal:  Arteriosclerosis        ISSN: 0276-5047


  12 in total

Review 1.  Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Authors:  Maureen McMahon; Bevra H Hahn; Brian J Skaggs
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

2.  Dyslipoproteinemia during the active course of systemic lupus erythematosus in association with anti-double-stranded DNA (anti-dsDNA) antibodies.

Authors:  Sara Kashef; Mohammad Mehdi Ghaedian; Akbar Rajaee; Abbas Ghaderi
Journal:  Rheumatol Int       Date:  2006-08-30       Impact factor: 2.631

3.  Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C.

Authors:  Hans L Tillmann; Keyur Patel; Andrew J Muir; Cynthia D Guy; Josephine H Li; Xiang Qian Lao; Alexander Thompson; Paul J Clark; Stephen D Gardner; John G McHutchison; Jeanette J McCarthy
Journal:  J Hepatol       Date:  2011-04-14       Impact factor: 25.083

4.  Antimicrobial activity of lipoprotein particles containing apolipoprotein Al.

Authors:  N Tada; T Sakamoto; A Kagami; K Mochizuki; K Kurosaka
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

5.  Interferon-lambda genotype and low serum low-density lipoprotein cholesterol levels in patients with chronic hepatitis C infection.

Authors:  Josephine H Li; Xiang Qian Lao; Hans L Tillmann; Jennifer Rowell; Keyur Patel; Alexander Thompson; Sunil Suchindran; Andrew J Muir; John R Guyton; Stephen D Gardner; John G McHutchison; Jeanette J McCarthy
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

6.  Remissions in newly diagnosed type 1 (insulin-dependent) diabetes: influence of interferon as an adjunct to insulin therapy.

Authors:  V A Koivisto; A Aro; K Cantell; M Haataja; J Huttunen; S L Karonen; P Mustajoki; R Pelkonen; P Seppälä
Journal:  Diabetologia       Date:  1984-08       Impact factor: 10.122

Review 7.  Cytochrome P450 and gene activation--from pharmacology to cholesterol elimination and regression of atherosclerosis.

Authors:  Pauli V Luoma
Journal:  Eur J Clin Pharmacol       Date:  2008-07-17       Impact factor: 2.953

8.  Dyslipidaemia in rheumatological autoimmune diseases.

Authors:  Tracey E Toms; Vasileios F Panoulas; George D Kitas
Journal:  Open Cardiovasc Med J       Date:  2011-02-24

9.  Impact of IL28B genetic variation on HCV-induced liver fibrosis, inflammation, and steatosis: a meta-analysis.

Authors:  Masaya Sato; Mayuko Kondo; Ryosuke Tateishi; Naoto Fujiwara; Naoya Kato; Haruhiko Yoshida; Masataka Taguri; Kazuhiko Koike
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

Review 10.  Interferon Control of the Sterol Metabolic Network: Bidirectional Molecular Circuitry-Mediating Host Protection.

Authors:  Kevin A Robertson; Peter Ghazal
Journal:  Front Immunol       Date:  2016-12-23       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.